|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：T321510 |
| 產(chǎn)品名稱(chēng)：Tezacaftor |
| 產(chǎn)品CAS：1152311-62-0 |
| 規(guī)格含量：5mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
T321510 |
| 名稱(chēng): |
Tezacaftor |
| 別名: |
1-(2,2-Difluoro-1,3-benzodioxol-5-yl)-N-[1-[(2R)-2,3-dihydroxypropyl]-6-fluoro-2-(2-hydroxy-1,1-dimethylethyl)-1H-indol-5-yl]cyclopropanecarboxamide; VX 661 |
| CAS號(hào): |
1152311-62-0 |
| 分子式: |
C??H??F?N?O? |
| 外觀: |
白色至Light Yellow Solid |
| 分子量: |
520.5 |
| 儲(chǔ)存: |
冰箱 |
| 溶解度: |
DMSO (Slightly), Methanol (Slightly) |
| 類(lèi)別: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
Tezacaftor is used as a combination therapy with Ivacaftor for the treatment of patients with cystic fibrosis. |
| 參考文獻(xiàn) |
|
|
|
|
?您的位置：
